Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Update on US regulatory review of Fasenra in chronic rhinosinusitis with nasal polyps
-
Lynparza approved in the US as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
-
Nirsevimab significantly protected infants against RSV disease in Phase III MELODY trial
-
AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement to develop and commercialise NI006
-
AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers
-
Enhertu significantly improved both progression-free and overall survival in DESTINY-Breast04 trial in patients with HER2-low metastatic breast cancer
-
Nirsevimab EMA regulatory submission accepted under accelerated assessment for RSV protection in all infants
-
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus
-
Lynparza plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st-line metastatic castration-resistant prostate cancer
-
Full-year and Q4 2021 results
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
